Skip to main content

Find Clinical Trials

Home
Conditions
Gaucher Disease

Clinical trial condition

Gaucher Disease

Explore clinical trials studying Gaucher Disease. Study availability and eligibility vary by location and protocol.

70 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Gaucher Disease trial results

Completed

A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

NCT00433147

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations: San Francisco, California, United States

Coral Springs, Florida, United States

Decatur, Georgia, United States

Iowa City, Iowa, United States

View Trial Details

Completed

A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

NCT01411228

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Shaare Zedek Medical Center Jerusalem, Israel

Instituto Privado de Hematologia E Investigacion Clinica (I.P.H.I.C) Barrio Asunción, Paraguay

Morningside Medi-Clinic Morningside, South Africa

View Trial Details

Completed

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

NCT00446550

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations: Beverly Hills, California, United States

Coral Springs, Florida, United States

Decatur, Georgia, United States

Iowa City, Iowa, United States

View Trial Details

Completed

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

NCT00813865

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations: Coral Springs, Florida, United States

Decatur, Georgia, United States

Boston, Massachusetts, United States

London, United Kingdom

View Trial Details

Completed

A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease

NCT00465062

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease

NCT00041535

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Institute of Child Health London, United Kingdom

View Trial Details

Completed

Exploration of Immunity in Gaucher Disease

NCT01358188

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations: Lysosomal Diseases Research and Treatment Center, CFCT Fairfax, Virginia, United States

View Trial Details

Completed

A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

NCT02536937

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Investigational Site Number 840004 Miami, Florida, United States

Investigational Site Number 840002 Saint Paul, Minnesota, United States

Investigational Site Number 840001 Knoxville, Tennessee, United States

View Trial Details

Completed

A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

NCT02536911

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Investigational Site Number 840002 Miami, Florida, United States

Investigational Site Number 840001 Knoxville, Tennessee, United States

View Trial Details

Completed

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

NCT01074944

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: University of California, San Diego Medical Center San Diego, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

Emory University Medical Center Decatur, Georgia, United States

Children's Memorial Hospital Chicago, Illinois, United States

View all 46 locations

View Trial Details